Survivorship outcomes in patients treated with immune checkpoint inhibitors: a scoping review

DC Güven, MSY Thong, V Arndt - Journal of Cancer Survivorship, 2024 - Springer
Abstract Background Immune checkpoint inhibitors (ICIs) have become a central part of
cancer care. However, the survivorship outcomes in patients treated with ICIs are …

Psychosocial aspects of living long term with advanced cancer and ongoing systemic treatment: a scoping review

EEM Kolsteren, E Deuning-Smit, AK Chu… - Cancers, 2022 - mdpi.com
Simple Summary An emerging group of advanced cancer patients are living long term on
systemic treatment. However, studies examining the psychosocial impact of this prolonged …

To be aware or not to be aware of the prognosis in the terminal stage of cancer? A systematic review of the associations between prognostic awareness with anxiety …

F Luciani, G Veneziani, E Giraldi, V Campedelli… - Clinical Psychology …, 2025 - Elsevier
Prognostic awareness (PA) has an important role in promoting informed care planning in
cancer patients. However, studies in the literature showed discordant results regarding the …

Fear of cancer recurrence in patients with localized renal cell carcinoma

CD Bergerot, D Battle, EJ Philip, PG Bergerot… - JCO Oncology …, 2020 - ascopubs.org
PURPOSE: Patients with cancer commonly report distress and fear of cancer recurrence
(FCR) impacting quality of life and clinical outcomes. This study aims to test the association …

Association of programmed cell death ligand 1 expression status with receipt of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer

MS Leapman, CJ Presley, W Zhu, PR Soulos… - JAMA Network …, 2020 - jamanetwork.com
Importance Initial approval for immune checkpoint inhibitors (ICIs) for treatment of advanced
non–small cell lung cancer (NSCLC) was limited to patients with high levels of programmed …

Patients' perceptions regarding the relevance of items contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19

CD Bergerot, J Malhotra, P Bergerot, EJ Philip… - The …, 2023 - academic.oup.com
Background There is a lack of consensus regarding the optimal method of assessing health-
related quality of life (HR-QOL) among patients with metastatic renal cell carcinoma …

Integration of Palliative and Supportive Care Into the Management of Genitourinary Malignancies.

B Saraiya, W Dale, EA Singer, D Cella - American Society of …, 2022 - europepmc.org
Patients with genitourinary malignancies are typically cared for by a multidisciplinary team of
urologists, medical oncologists, and radiation oncologists. For the past decade, integration …

Perceptions and Expectations: A Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer

H Bolek, C Arslan, M Basaran, İ Cicin… - JCO Global …, 2024 - ascopubs.org
PURPOSE Durable complete response rates for metastatic renal cell carcinoma (mRCC)
and metastatic bladder cancer (mBC) are low despite new therapy. Palliative care focuses …

Pre-treatment expectations of patients with spinal metastases: what do we know and what can we learn from other disciplines? A systematic review of qualitative …

R Gal, D Oostinga, H Wessels, JJ Verlaan… - BMC cancer, 2020 - Springer
Background Little is known about treatment expectations of patients with spinal metastases
undergoing radiotherapy and/or surgery. Assuming that patients with spinal metastases …

Patient perceptions of treatment benefit and toxicity in advanced cancer: a prospective cross-sectional study

R Patell, D Einstein, E Miller, L Dodge… - JCO Oncology …, 2021 - ascopubs.org
PURPOSE: Prior studies show that many patients receiving palliative cancer therapies
misperceive likelihood of cure. Patients' understanding of treatment benefits and risks …